Current Classification and Management of Inflammatory Myopathies.
Schmidt J.
J Neuromuscul Dis. 2018;5(2):109-129. doi: 10.3233/JND-180308.
Polymyositis-dermatomyositis and infections.
Zampieri S, Ghirardello A, Iaccarino L, Briani C, Sarzi-Puttini P, Atzeni F, Arienti S, Todesco S, Doria A.
Autoimmunity. 2006 May;39(3):191-6. doi: 10.1080/08916930600622348.
Polymyositis and dermatomyositis biomarkers.
Xu S, Hu X, Wang J, Xu Q, Han Z, Zhou H, Gao M.
Clin Chim Acta. 2023 Jul 1;547:117443. doi: 10.1016/j.cca.2023.117443. Epub 2023 Jun 15.
The Mythology of Polymyositis.
Biliciler S, Mozaffar T.
Rheum Dis Clin North Am. 2025 Nov;51(4):777-788. doi: 10.1016/j.rdc.2025.07.015. Epub 2025 Sep 9.
Juvenile dermatomyositis/polymyositis and lymphoma.
Stübgen JP.
J Neurol Sci. 2017 Jun 15;377:19-24. doi: 10.1016/j.jns.2017.03.033. Epub 2017 Mar 27.
[Inflammatory myopathies].
Cherin P.
Rev Prat. 2001 Feb 15;51(3):270-7.
Inflammatory muscle diseases.
Mastaglia FL.
Neurol India. 2008 Jul-Sep;56(3):263-70. doi: 10.4103/0028-3886.43444.
Idiopathic inflammatory myopathies.
Dimachkie MM, Barohn RJ.
Semin Neurol. 2012 Jul;32(3):227-36. doi: 10.1055/s-0032-1329201. Epub 2012 Nov 1.
The diagnosis and classification of polymyositis.
Milisenda JC, Selva-O'Callaghan A, Grau JM.
J Autoimmun. 2014 Feb-Mar;48-49:118-21. doi: 10.1016/j.jaut.2014.01.025. Epub 2014 Jan 22.
Risk of Malignancy in Dermatomyositis and Polymyositis.
Qiang JK, Kim WB, Baibergenova A, Alhusayen R.
J Cutan Med Surg. 2017 Mar/Apr;21(2):131-136. doi: 10.1177/1203475416665601. Epub 2016 Aug 20.
